13F

Stock

Acadia Pharmaceuticals Inc

ACAD · held by 2 managers

Reported value

$4.86M

Holders

2

+1 new · −0 exited

Holders’ est. mark

−$589.5K

Price effect on 1 books still in the name

Largest holder

$4.53M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC217.3K$4.53M−$589.5KCut−$11.6K
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main15.8K$329.9KNew

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.